Publicacións en colaboración con investigadores/as de Karolinska Institute (57)

2024

  1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

  2. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

    Nature Communications, Vol. 15, Núm. 1

  3. Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure

    American Heart Journal, Vol. 267, pp. 52-61

  4. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

  5. Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group

    Clinical Microbiology and Infection

2023

  1. Age and Sex Determine Electrocardiogram Parameters in the Octodon degus

    Biology, Vol. 12, Núm. 5

  2. Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (Nature Genetics, (2023), 55, 1, (89-99), 10.1038/s41588-022-01222-9)

    Nature Genetics

  3. Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry

    European journal of preventive cardiology, Vol. 30, Núm. 13, pp. 1346-1358

  4. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

    Nature Genetics, Vol. 55, Núm. 1, pp. 89-99

  5. How does age affect outcomes after left ventricular assist device implantation: results from the PCHF-VAD registry

    ESC Heart Failure, Vol. 10, Núm. 2, pp. 884-894

  6. Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes – from the ESC-HFA EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 25, Núm. 9, pp. 1571-1583

  7. Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry

    European Heart Journal, Vol. 44, Núm. 17, pp. 1526-1529

  8. Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 25, Núm. 7, pp. 1049-1060

  9. Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC-HFA Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 25, Núm. 7, pp. 1061-1071

  10. Sex-related differences in left ventricular assist device utilization and outcomes: results from the PCHF-VAD registry

    ESC Heart Failure, Vol. 10, Núm. 2, pp. 1054-1065

2022

  1. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC-HFA EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 335-350

  2. Erratum to: Is Sensory Loss an Understudied Risk Factor for Frailty? A Systematic Review and Meta-analysis

    The journals of gerontology. Series A, Biological sciences and medical sciences

  3. Impact of progressive aortic regurgitation on outcomes after left ventricular assist device implantation

    Heart and Vessels, Vol. 37, Núm. 12, pp. 1985-1994

  4. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator

    European heart journal, Vol. 43, Núm. 32, pp. 3053-3067

  5. Improved survival of left ventricular assist device carriers in Europe according to implantation eras: results from the PCHF-VAD registry

    European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1305-1315